• 

  Trojan Horse: Carrying Alzheimer’s Antibodies Into the Brain
• 

  It Takes Tau to Tangle: Is Faster Buildup Driving Women’s Alzheimer’s Risk?
• 

  Traumatic Brain Injuries Have Long-tail Toxic Effects — Could an Antioxidant Help Ease Them?
• 

  Journey to Diagnosis: Real-Life, Personal Stories of Navigating Cognitive Decline
• 

  How to Respond to People With Dementia Who Think They’re in a Different Time or Place
• 

  In Trials: A Powerful Magnet for Zapping Alzheimer’s Away
• 

  States Propose Bills to Make Private Insurers Cover Approved Alzheimer’s Drugs, Diagnostics
• 

  Curing Alzheimer’s Disease: Magic Bullet or Magic Shotgun Blast?
• 

  What Can We Learn About Dementia from LGBTQ+ Brain Health Research?
• 

  Alzheon Alzheimer’s Pill Misses the Mark in Phase 3 Trial, Hints at Benefit in MCI
• 

  Daniel Avesar: Understanding His Own Brain Changes After a Traumatic Brain Injury
• 

  After Two Phase 3 Trial Fails, Cassava Sciences Gives Up On Alzheimer’s Drugs
• 

  No Kisunla in Europe: Regulators Reject Lilly’s Alzheimer’s ‘Mab’ Drug
• 

  Why Neglecting Your Brain Health Can Make It Harder to Achieve Physical Goals
• 

  An Alzheimer’s Carer’s Primer on ‘Respite Care’ for Caregivers

Previous141516Next